BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36309603)

  • 1. Reply to Letter to the Editor regarding "Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis".
    De Virgilio A; Costantino A; Festa BM; Mercante G; Franceschini D; Franzese C; Scorsetti M; Marrari A; Cavina R; Marano S; Castoro C; Spriano G
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1369-1371. PubMed ID: 36309603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis.
    De Virgilio A; Costantino A; Festa BM; Mercante G; Franceschini D; Franzese C; Scorsetti M; Marrari A; Cavina R; Marano S; Castoro C; Spriano G
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1029-1041. PubMed ID: 35235020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al.
    Guler OC; Onal C
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2567-2568. PubMed ID: 35697858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Definitive Chemoradiotherapy for Cervical and Upper Thoracic Esophageal Cancers: a Single-Institution Experience of a Rare Cancer.
    Esmati E; Maddah Safaei A; Ghalehtaki R; Mousavi N; Saraee E; Shirouei S; Mohammadi N; Lashkari M
    J Gastrointest Cancer; 2019 Sep; 50(3):380-385. PubMed ID: 29497928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis.
    Luo HS; Huang HC; Lin LX
    Radiat Oncol; 2019 Oct; 14(1):178. PubMed ID: 31623639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
    Ikawa T; Ishihara R; Matsueda K; Konishi K; Yamamoto S; Morimoto M; Kanayama N; Teshima T
    BMC Cancer; 2022 Mar; 22(1):301. PubMed ID: 35313853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis.
    Song T; Liang X; Fang M; Wu S
    Expert Rev Anticancer Ther; 2015; 15(10):1157-69. PubMed ID: 26235427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for Cervical Esophageal Squamous Cell Carcinoma.
    Kwong DLW; Chan WWL; Lam KO
    Methods Mol Biol; 2020; 2129():295-305. PubMed ID: 32056186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy for Thoracic Esophageal Squamous Cell Carcinoma.
    Chan WWL; Lam KO; Kwong DLW
    Methods Mol Biol; 2020; 2129():307-319. PubMed ID: 32056187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stricture rate after chemoradiotherapy and radiotherapy for oesophageal squamous cell carcinoma: a 20-year experience.
    Hamer PW; Hight SC; Ward IG; Harris DL; Woodham BL; Flint RS
    ANZ J Surg; 2019 Apr; 89(4):367-371. PubMed ID: 30791194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
    Honma Y; Nagashima K; Hirano H; Shoji H; Iwasa S; Takashima A; Okita N; Kato K; Boku N; Murakami N; Inaba K; Ito Y; Itami J; Kanamori J; Oguma J; Daiko H
    Cancer Med; 2020 Jan; 9(2):595-604. PubMed ID: 31794158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
    Xu X; Wang Z; Jiang S; Shang Y; Wu Y
    Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
    de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
    Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Watanabe M; Mine S; Yamada K; Shigaki H; Baba Y; Yoshida N; Kajiyama K; Yamamoto N; Sano T; Baba H
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):685-92. PubMed ID: 24965711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.